Keros Therapeutics, Inc. (KROS)
Nasdaq: KROS · CIK 0001664710 · United States
Every official Keros Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open KROS filings
Keros Therapeutics, Inc. documents
- Keros Therapeutics, Inc. 10-K 2026KROS 10-K 2026: annual report for fiscal 2026
- Keros Therapeutics, Inc. 10-K 2025KROS 10-K 2025: annual report for fiscal 2025
- Keros Therapeutics, Inc. 10-K 2024KROS 10-K 2024: annual report for fiscal 2024
- Keros Therapeutics, Inc. 10-K 2023KROS 10-K 2023: annual report for fiscal 2023
- Keros Therapeutics, Inc. 10-K 2022KROS 10-K 2022: annual report for fiscal 2022
- Keros Therapeutics, Inc. 10-Q 2026KROS 10-Q 2026: quarterly report for fiscal 2026
- Keros Therapeutics, Inc. 10-Q 2025KROS 10-Q 2025: quarterly report for fiscal 2025
- Keros Therapeutics, Inc. 10-Q 2024KROS 10-Q 2024: quarterly report for fiscal 2024
- Keros Therapeutics, Inc. 10-Q 2023KROS 10-Q 2023: quarterly report for fiscal 2023
- Keros Therapeutics, Inc. 10-Q 2022KROS 10-Q 2022: quarterly report for fiscal 2022
- Keros Therapeutics, Inc. 8-K 2026KROS 8-K 2026: current report for fiscal 2026
- Keros Therapeutics, Inc. 8-K 2025KROS 8-K 2025: current report for fiscal 2025
- Keros Therapeutics, Inc. 8-K 2024KROS 8-K 2024: current report for fiscal 2024
- Keros Therapeutics, Inc. 8-K 2023KROS 8-K 2023: current report for fiscal 2023
- Keros Therapeutics, Inc. 8-K 2022KROS 8-K 2022: current report for fiscal 2022
- Keros Therapeutics, Inc. DEF 14A 2026KROS DEF 14A 2026: proxy statement for fiscal 2026
- Keros Therapeutics, Inc. DEF 14A 2025KROS DEF 14A 2025: proxy statement for fiscal 2025
- Keros Therapeutics, Inc. DEF 14A 2024KROS DEF 14A 2024: proxy statement for fiscal 2024
- Keros Therapeutics, Inc. DEF 14A 2023KROS DEF 14A 2023: proxy statement for fiscal 2023
- Keros Therapeutics, Inc. DEF 14A 2022KROS DEF 14A 2022: proxy statement for fiscal 2022
- Keros Therapeutics, Inc. Form 4 2026KROS Form 4 2026: insider trading filing for fiscal 2026
- Keros Therapeutics, Inc. Form 4 2025KROS Form 4 2025: insider trading filing for fiscal 2025
- Keros Therapeutics, Inc. Form 4 2024KROS Form 4 2024: insider trading filing for fiscal 2024
- Keros Therapeutics, Inc. Form 4 2023KROS Form 4 2023: insider trading filing for fiscal 2023
- Keros Therapeutics, Inc. Form 4 2022KROS Form 4 2022: insider trading filing for fiscal 2022
- Keros Therapeutics, Inc. S-1 2026KROS S-1 2026: registration statement for fiscal 2026
- Keros Therapeutics, Inc. S-1 2025KROS S-1 2025: registration statement for fiscal 2025
- Keros Therapeutics, Inc. S-1 2024KROS S-1 2024: registration statement for fiscal 2024
- Keros Therapeutics, Inc. S-1 2023KROS S-1 2023: registration statement for fiscal 2023
- Keros Therapeutics, Inc. S-1 2022KROS S-1 2022: registration statement for fiscal 2022
- Keros Therapeutics, Inc. 13F 2026KROS 13F 2026: institutional holdings for fiscal 2026
- Keros Therapeutics, Inc. 13F 2025KROS 13F 2025: institutional holdings for fiscal 2025
- Keros Therapeutics, Inc. 13F 2024KROS 13F 2024: institutional holdings for fiscal 2024
- Keros Therapeutics, Inc. 13F 2023KROS 13F 2023: institutional holdings for fiscal 2023
- Keros Therapeutics, Inc. 13F 2022KROS 13F 2022: institutional holdings for fiscal 2022
More companies